Skip to main content
. Author manuscript; available in PMC: 2020 Aug 26.
Published in final edited form as: Arthritis Care Res (Hoboken). 2019 Jun 11;71(7):925–935. doi: 10.1002/acr.23723

Table 3:

Known-group validity for PF10a using Cohen’s d effect size

Age Clinical disease activity

<50 years ≥65 years CDAI ≤10 CDAI >22

N N Difference in mean PF10a Cohen’s d N N Difference in mean PF10a Cohen’s d
Language
 English 176 155 2.5* 0.24* 263 113 13.3* 1.44*
 Spanish 9 18 6.6 0.69 18 13 11.6* 1.21*
 Chinese 3 26 4.2 0.44 11 9 10.9* 0.95*
Insurance
 Private 131 12 6.1* 0.64* 140 50 16.5* 2.15*
 Medicare 22 184 −6.0* −0.59* 131 55 9.9* 1.04*
 Medicaid 35 3 −8.6 −1.00 21 30 9.6* 1.06*
Race/Ethnicity
 White 94 94 2.3 0.23 161 54 13.3* 1.49*
 African American 6 16 0.8 0.07 15 10 9.9* 0.96*
 Hispanic 12 3 0.9 0.09 13 6 5.3 0.48
 Asian 28 50 6.6* 0.64* 47 28 13.6* 1.37*
 Other 48 36 3.8 0.36 56 37 13.7* 1.50*

Data source: Cross-sectional sample (N=595)

CDAI: Clinical disease activity index; PF10a: Physical function short-form 10a

Difference in mean PF10a score is the difference between mean PF10a among those <50 years compared to those ≥65 years or among those with CDAI ≤10 compared to those with CDAI >22; Cohen’s d is the difference in mean scores divided by the pooled standard deviation; Effect size (Cohen’s d) values are categorized as small (<0.5), medium (0.5-0.8), or large (>0.8).

*

P<0.05 using Student’s t-test; for Cohen’s d, 95% confidence intervals do not cross 0